Assertio Holdings Gross Margin 2012-2026 | ASRT

Current and historical gross margin for Assertio Holdings (ASRT) over the last 10 years. The current gross profit margin for Assertio Holdings as of March 31, 2026 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Assertio Holdings Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2026-03-31 $0.10B $0.07B 70.59%
2025-12-31 $0.12B $0.08B 71.19%
2025-09-30 $0.14B $0.10B 69.85%
2025-06-30 $0.12B $0.08B 69.83%
2025-03-31 $0.12B $0.08B 71.19%
2024-12-31 $0.12B $0.09B 69.35%
2024-09-30 $0.13B $0.09B 70.40%
2024-06-30 $0.13B $0.10B 71.97%
2024-03-31 $0.14B $0.11B 76.76%
2023-12-31 $0.15B $0.13B 82.24%
2023-09-30 $0.17B $0.15B 86.39%
2023-06-30 $0.17B $0.15B 88.02%
2023-03-31 $0.16B $0.14B 88.20%
2022-12-31 $0.16B $0.14B 87.82%
2022-09-30 $0.14B $0.12B 87.05%
2022-06-30 $0.13B $0.11B 86.92%
2022-03-31 $0.12B $0.10B 85.83%
2021-12-31 $0.11B $0.09B 85.45%
2021-09-30 $0.11B $0.09B 83.18%
2021-06-30 $0.12B $0.10B 81.20%
2021-03-31 $0.11B $0.09B 78.76%
2020-12-31 $0.11B $0.09B 80.37%
2020-09-30 $0.14B $0.12B 88.24%
2020-06-30 $0.16B $0.15B 92.95%
2020-03-31 $0.19B $0.19B 96.35%
2019-12-31 $0.23B $0.22B 96.07%
2019-09-30 $0.21B $0.21B 96.24%
2019-06-30 $0.24B $0.23B 96.60%
2019-03-31 $0.24B $0.23B 96.68%
2018-12-31 $0.31B $0.29B 94.53%
2018-09-30 $0.36B $0.33B 90.88%
2018-06-30 $0.38B $0.33B 87.37%
2018-03-31 $0.42B $0.35B 84.41%
2017-12-31 $0.38B $0.31B 81.53%
2017-09-30 $0.41B $0.33B 81.42%
2017-06-30 $0.43B $0.35B 81.18%
2017-03-31 $0.44B $0.36B 81.45%
2016-12-31 $0.46B $0.37B 80.53%
2016-09-30 $0.44B $0.36B 80.41%
2016-06-30 $0.44B $0.35B 80.14%
2016-03-31 $0.42B $0.33B 78.61%
2015-12-31 $0.34B $0.28B 80.17%
2015-09-30 $0.43B $0.38B 88.06%
2015-06-30 $0.37B $0.34B 91.15%
2015-03-31 $0.35B $0.33B 95.66%
2014-12-31 $0.39B $0.38B 95.91%
2014-09-30 $0.24B $0.22B 93.67%
2014-06-30 $0.22B $0.21B 94.17%
2014-03-31 $0.19B $0.18B 94.59%
2013-12-31 $0.13B $0.13B 94.78%
2013-09-30 $0.12B $0.11B 94.17%
2013-06-30 $0.12B $0.11B 93.97%
2013-03-31 $0.10B $0.09B 94.00%
2012-12-31 $0.09B $0.09B 93.41%
2012-09-30 $0.08B $0.07B 96.05%
2012-06-30 $0.06B $0.06B 93.33%
2012-03-31 $0.07B $0.06B 92.54%
2011-12-31 $0.13B $0.13B 95.49%
2011-09-30 $0.14B $0.14B 95.07%
2011-06-30 $0.15B $0.14B 95.17%
2011-03-31 $0.15B $0.14B 94.59%
2010-12-31 $0.08B $0.07B 91.25%
2010-09-30 $0.07B $0.07B 90.28%
2010-06-30 $0.08B $0.07B 92.00%
2010-03-31 $0.06B $0.06B 92.06%
2009-12-31 $0.06B $0.05B 91.38%
2009-09-30 $0.05B $0.05B 90.74%
2009-06-30 $0.05B $0.04B 86.67%
2009-03-31 $0.04B $0.03B 87.18%
2008-12-31 $0.04B $0.03B 82.86%
2008-09-30 $0.03B $0.03B 80.65%
2008-06-30 $0.07B $0.07B 92.86%
2008-03-31 $0.07B $0.06B 92.65%
2007-12-31 $0.07B $0.06B 95.45%
2007-09-30 $0.07B $0.06B 96.97%
2007-06-30 $0.01B $0.01B 92.86%
2007-03-31 $0.01B $0.01B 91.67%
2006-12-31 $0.01B $0.01B 88.89%
2006-09-30 $0.01B $0.01B 85.71%
2006-06-30 $0.01B $0.01B 85.71%
2006-03-31 $0.01B $0.01B 100.00%
2005-12-31 $0.00B $0.00B 100.00%
2005-09-30 $0.00B $0.00B 100.00%
2005-06-30 $0.00B 0 0.00%
2004-12-31 $0.00B 0 0.00%
2004-09-30 $0.00B 0 0.00%
2004-03-31 $0.00B 0 0.00%
2003-12-31 $0.00B 0 0.00%
2003-09-30 $0.00B 0 0.00%
2003-06-30 $0.00B 0 0.00%
2003-03-31 $0.00B $0.00B 100.00%
2002-12-31 $0.00B $0.00B 100.00%
2002-09-30 $0.00B $0.00B 100.00%
2002-06-30 $0.00B $0.00B 100.00%
2002-03-31 $0.00B $0.00B 100.00%
2001-12-31 $0.00B $0.00B 100.00%
2001-09-30 $0.00B $0.00B 100.00%
2001-06-30 $0.00B $0.00B 100.00%
2001-03-31 $0.00B $0.00B 100.00%
2000-12-31 $0.00B $0.00B 100.00%
1999-03-31 $0.00B 0 0.00%
1998-12-31 $0.00B 0 0.00%
1998-09-30 $0.00B 0 0.00%
1998-06-30 $0.00B 0 0.00%
1998-03-31 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.116B $0.119B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
USANA Health Sciences (USNA) United States $0.275B 15.05
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00